MAM
COCH icon

Marquette Asset Management’s Envoy Medical COCH Stock Holding History

Marquette Asset Management’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,718
Closed -$38.1K – 195
2024
Q3 		$38.1K Hold
11,718
– – 0.01% 174
2024
Q2 		$27.7K Buy
+11,718
New +$43.6K ﹤0.01% 153

Other funds holding COCH

AMC
Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCA
DSG Capital Advisors Edina, Minnesota $625M AUM 30.33% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HAG
HighPoint Advisor Group Downers Grove, Illinois $2.39B AUM 28.86% 1-Year Est. Return

Marquette Asset Management's COCH Position: Q4 2024 in Review

Marquette Asset Management sold out of Envoy Medical (COCH) in Q4 2024, closing a stake of 11,718 shares — an estimated $38.1K sold.

Marquette Asset Management first reported a position in COCH in Q2 2024 and held it in 2 quarters. The position peaked at $38.1K in Q3 2024. 24 funds tracked by Wall St. Rank hold COCH as of Q4 2024.

  • Marquette Asset Management reported no remaining Envoy Medical position as of Q4 2024 after selling out during the quarter.
  • Marquette Asset Management sold 11,718 Envoy Medical shares in Q4 2024, an estimated $38.1K.
  • Marquette Asset Management first reported a position in Envoy Medical in Q2 2024 and held it in 2 quarters.
  • Marquette Asset Management's Envoy Medical position peaked at $38.1K in Q3 2024.
  • 24 funds tracked by Wall St. Rank held Envoy Medical as of Q4 2024.

Based on Marquette Asset Management's 13F filing for Q4 2024, filed 14 Jan 2025.